文献速递胸部技术与安全CT

国家肺癌筛查试验胸部CT筛查中按体型计算的器官剂量与有效剂量

Body Size-Specific Organ and Effective Doses of Chest CT Screening Examinations of the National Lung Screening Trial.
PubMed 文献 · AJR Am J Roentgenol · 2017-03-07

该研究基于国家肺癌筛查试验(NLST)23,734名接受低剂量CT筛查的参与者,使用NCICT剂量计算程序按体型计算器官剂量和有效剂量,并与参考体型模体剂量系数比较。结果显示,体重过轻者肺剂量中位数4.93 mGy,肥胖者3.90 mGy;甲状腺剂量为肺剂量的约1.3–1.6倍;参考模体法低估体重过轻者肺剂量达50%,高估超重者达200%。

要点

  • 按体型计算时,体重过轻者肺剂量中位数4.93 mGy,肥胖者3.90 mGy,前者约为后者的1.3倍。
  • 甲状腺剂量约为肺剂量的1.3–1.6倍(6.3–6.5 mGy)。
  • 参考体型模体法低估体重过轻者肺剂量达50%,高估超重者达200%。

核心结论

  • 对23,734名NLST低剂量CT筛查参与者按体型计算了器官剂量和有效剂量;当剂量评估未考虑体型时,使用参考体型模体会导致器官剂量估计的显著误差。

研究设计与样本

  • 研究收集23,734名NLST参与者接受CT检查的技术参数,使用基于体型依赖成人男女计算模体库剂量系数的NCICT剂量计算程序按体型计算器官剂量和有效剂量,并用参考体型模体剂量系数重新计算以评估误差。

诊断标准与关键数值

  • 体重过轻(BMI<18.5)参与者肺剂量中位数4.93 mGy,肥胖(BMI>30)参与者3.90 mGy,前者为后者的1.3倍。
  • 甲状腺剂量约为肺剂量的1.3–1.6倍,为6.3–6.5 mGy。
  • 参考模体法低估体重过轻参与者体型特异性肺剂量达50%,高估超重参与者该值达200%。
  • 有效剂量中位数从肥胖参与者的2.01 mSv到体重过轻参与者的2.80 mSv。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: We calculated body size-specific organ and effective doses for 23,734 participants in the National Lung Screening Trial (NLST) using a CT dose calculator.

MATERIALS AND METHODS: We collected participant-specific technical parameters of 23,734 participants who underwent CT in the clinical trial. For each participant, we calculated two sets of organ doses using two methods. First, we computed body size-specific organ and effective doses using the National Cancer Institute CT (NCICT) dosimetry program, which is based on dose coefficients derived from a library of body size-dependent adult male and female computational phantoms. We then recalculated organ and effective doses using dose coefficients from reference size phantoms for all examinations to investigate potential errors caused by the lack of body size consideration in the dose calculations.

RESULTS: The underweight participants (body mass index [BMI; weight in kilograms divided by the square of height in meters] < 18.5) received 1.3-fold greater lung dose (median, 4.93 mGy) than the obese participants (BMI > 30) (3.90 mGy). Thyroid doses were approximately 1.3- to 1.6-fold greater than the lung doses (6.3-6.5 mGy). The reference phantom-based dose calculation underestimates the body size-specific lung dose by up to 50% for the underweight participants and overestimates that value by up to 200% for the overweight participants. The median effective dose ranges from 2.01 mSv in obese participants to 2.80 mSv in underweight participants.

CONCLUSION: Body size-specific organ and effective doses were computed for 23,734 NLST participants who underwent low-dose CT screening. The use of reference size phantoms can lead to significant errors in organ dose estimates when body size is not considered in the dose assessment.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lee C, Flynn MJ, Judy PF, et al. Body Size-Specific Organ and Effective Doses of Chest CT Screening Examinations of the National Lung Screening Trial. AJR Am J Roentgenol. 2017. PMID: 28267354. doi:10.2214/AJR.16.16979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。